CAS: 72702-95-5 - Ponalrestat
Fórmula:C17H12BrFN2O3
InChI:InChI=1/C17H12BrFN2O3/c18-11-6-5-10(14(19)7-11)9-21-17(24)13-4-2-1-3-12(13)15(20-21)8-16(22)23/h1-7H,8-9H2,(H,22,23)
- Sinónimos:
- Ponalrestat [USAN:INN:BAN]
- 1-Phthalazineacetic acid, 3-((4-bromo-2-fluorophenyl)methyl)-3,4-dihydro-4-oxo-
- 3-(4-Bromo-2-fluorobenzyl)-3,4-dihydro-4-oxo-1-phthalazineacetic acid
- Ici 128,436
- Ponalrestatum
- Ponalrestatum [Latin]
- Unii-2Cv0A5G64E
- [3-(4-Bromo-2-Fluorobenzyl)-4-Oxo-3,4-Dihydrophthalazin-1-Yl]Acetic Acid
1-Phthalazineaceticacid, 3-[(4-bromo-2-fluorophenyl)methyl]-3,4-dihydro-4-oxo-
CAS:72702-95-5
Fórmula:
C17H12BrFN2O3
Pureza:
97%
Forma y color:
Solid
Peso molecular:
391.1912
Ref: AN-AG005PTL
25mg | 113,00 € | |
50mg | 187,00 € | |
100mg | 228,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
Ponalrestat
CAS:72702-95-5
Ponalrestat is an aldose reductase inhibitor.
Fórmula:
C17H12BrFN2O3
Pureza:
99.86%
Forma y color:
Solid
Peso molecular:
391.19
Ref: TM-T2013
10mg | 46,00 € | |
25mg | A consultar | |
50mg | A consultar | |
1ml*10 (DMSO) | 50,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
Ponalrestat
CAS:72702-95-5
Ponalrestat is a drug that has been developed to treat metabolic disorders, such as diabetic …
Fórmula:
C17H12BrFN2O3
Pureza:
Min. 98 Area-%
Forma y color:
Powder
Peso molecular:
391.19 g/mol
Ref: 3D-FP102755
25mg | 98,00 € | |
50mg | 146,00 € | |
100mg | 219,00 € | |
250mg | 430,00 € | |
500mg | 633,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
Ponalrestat - Bio-X ™
CAS:72702-95-5
This product is part of our Bio-X ™ Range. These products are aimed at life …
Fórmula:
C17H12BrFN2O3
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
391.19 g/mol
Ref: 3D-BP300109
10mg | 109,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024